abstract |
This invention relates to quinolinalquinoxaline compounds of the formula (1) (see formula) that inhibit the activity of platelet-derived growth factor or p56lck tyrosine kinase activity, pharmaceutical compositions comprising these compounds, as well as the use of these compounds. to treat a patient who suffers or is subject to disorders / conditions that involve differentiation, cell proliferation, extracellular matrix production or mediator release and / or activation and proliferation of T cells. |